Decoy Biosystems Overview

  • Founded
  • 2013
Founded
  • Status
  • Private
  • Employees
  • 1
Employees
  • Latest Deal Type
  • Early Stage VC
  • Latest Deal Amount
  • $6.02M
Latest Deal Amount
  • Investors
  • 4

Decoy Biosystems General Information

Description

Provider of novel anti-cancer and anti-viral immunotherapy designed to eliminate viral and bacterial infections. The company's immunotherapy eradicates existing tumors with the induction of immunological memory in standard pre-clinical models and is also active against established human hepatitis b and hiv infection in standard pre-clinical models, enabling researchers to modify and kill non-pathogenic bacteria utilized in biotherapy.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Delivery
Primary Office
  • 3210 Merryfield Row
  • San Diego, CA 92121
  • United States
+1 (858) 000-0000

Decoy Biosystems Timeline

2018201920202021
Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Decoy Biosystems Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC 01-Oct-2018 $6.02M 00.000 0000 Completed Pre-Clinical Trials
2. Accelerator/Incubator 06-Aug-2018 00.00 Completed Pre-Clinical Trials
1. Angel (individual) $1.5M $1.5M Completed Startup
To view Decoy Biosystems’s complete valuation and funding history, request access »

Decoy Biosystems Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed 000,000 00.000000 000.00 000.00 00 000.00 000
To view Decoy Biosystems’s complete cap table history, request access »

Decoy Biosystems Executive Team (3)

Name Title Board Seat Contact Info
Michael Newman Ph.D Founder, Chief Executive Officer, President & Board Member
Stella Sung Ph.D Chief Business Officer
Neil Clendeninn Ph.D Chief Medical Officer
To view Decoy Biosystems’s complete executive team members history, request access »

Decoy Biosystems Board Members (3)

Name Representing Role Since
Brian O'Callaghan Self Board Member 000 0000
Hoonmo Lee TY BIO Investment Board Member 000 0000
Michael Newman Ph.D Decoy Biosystems Founder, Chief Executive Officer, President & Board Member 000 0000
To view Decoy Biosystems’s complete board members history, request access »

Decoy Biosystems Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Decoy Biosystems Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Mountain Pacific Venture Partners Venture Capital Minority 000 0000 000000 0
Savantus Ventures Venture Capital Minority 000 0000 000000 0
TY BIO Investment Venture Capital Minority 000 0000 000000 0
JLABS Accelerator/Incubator Minority 000 0000 000000 0
To view Decoy Biosystems’s complete investors history, request access »